Status:
COMPLETED
Interstitial Lung Disease Within a Lung Cancer Screening
Lead Sponsor:
Manchester University NHS Foundation Trust
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
50-80 years
Brief Summary
Interstitial lung disease is a devastating lung condition with terrible outcomes. Lung cancer is the world's leading cause of cancer related death. Unlike breast and bowel cancer, there is no lung can...
Detailed Description
The Manchester Early Detection of Lung Disease Pilot (lung cancer screening programme) is already under way and has been for the past 12 months. A total of 1,384 individuals had a CT scan as part of t...
Eligibility Criteria
Inclusion
- Age 50-80
- Ever-smoker
- MDT diagnosis of ILD that has been detected through lung cancer screening or standard non-screening pathway
- Attended the regional ILD clinic
Exclusion
- Unable to complete self-report questionnaire measures
- Unable to provide written informed consent
Key Trial Info
Start Date :
November 11 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04715347
Start Date
November 11 2017
End Date
June 30 2020
Last Update
July 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester University NHS foundation trust
Manchester, Greater Manchester, United Kingdom, M13 9WL